The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.
The Scientist
Most Recent
Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?
How to successfully surmount the challenges women face in becoming biotech industry leaders
The high court considers the legitimacy of a patent on the relationship between blood tests and patient health.
The high court in Europe decided that researchers are barred from filing EU patents on work involving human embryonic stem cells.
Dropped from a patent lawsuit, at least one lab will be allowed to continue research on mouse models of Alzheimer’s disease.
A US federal appeals court says human genes are patentable.
As seven of the world’s top selling drugs expire over the next year, prescription prices are set to drop while generics fill in.
To meet the agricultural demands of the growing population, appropriate technology transfer incentives are a must.
Legal battles over gene patents and uncooperative patent holders threaten the widespread implementation of personalized medicine
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
